Vascular Solutions
Advanced cardiovascular imaging analysis and quantification solutions
Company profile
Company profile
Pie Medical Imaging BV is a Netherlands-based company specializing in advanced cardiovascular imaging software solutions. The company develops quantitative analysis tools for interventional cardiology, vascular imaging, and cardiac diagnostics that enable precise measurements and assessments of cardiovascular conditions. Their technology supports clinicians in making informed treatment decisions through sophisticated image analysis capabilities. Pie Medical Imaging serves healthcare providers, hospitals, and medical device manufacturers globally, providing both standalone software solutions and integrated imaging analysis platforms. The company's products are designed to work with various imaging modalities including angiography, CT, MRI, and ultrasound systems. With a focus on cardiovascular specialties, Pie Medical Imaging has established itself as a provider of clinical-grade imaging analysis tools that support both routine clinical practice and advanced research applications in cardiology and vascular medicine.
Company description Pie Medical Imaging BV official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
On Premise deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Advanced cardiovascular imaging analysis and quantification solutions
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · May 1, 2026
Reference Values for Myocardial Strain by Cardiac Magnetic Resonance Feature Tracking: Insights From Healthy Volunteers and Heart Failure Patients Using Caas MR.Reviews in cardiovascular medicine · Jan 1, 2026
Fully Automated Valve Segmentation for Blood Flow Assessment From 4D Flow MRI Including Automated Cardiac Valve Tracking and Transvalvular Velocity Mapping.Journal of magnetic resonance imaging : JMRI · Jan 1, 2025
Influence of intracoronary hemodynamic forces on atherosclerotic plaque phenotypes.International journal of cardiology · Mar 15, 2024
DEcreased Cognitive functiON, NEurovascular CorrelaTes and myocardial changes in women with a history of pre-eclampsia (DECONNECT): research protocol for a cross-sectional pilot study.BMJ open · Mar 4, 2024
Blood Flow Energy Identifies Coronary Lesions Culprit of Future Myocardial Infarction.Annals of biomedical engineering · Feb 1, 2024
Clinical validation
No linked records are currently available.
Regulatory
K250330 · 510k · Nov 3, 2025
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Pie Medical Imaging BV's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.